Guideline-Concordant Surgery, Adjuvant Therapy, and the Promise of Curative-Intent Lung Cancer Surgery: What Are We Up Against?
In a “tale of two trials,” Drs. Ogbeide and Osarogiagbon use insights from the ALCHEMIST trial population to try to understand outcomes disparities between North America and Japan. Read more
Undruggable No More: KRAS Experts Review What is Known—and Unknown—About This Challenging Alteration
Beyond sotorasib, dozens of small molecule inhibitors are being explored to target this oncogenic driver. Get up to date as researchers from Roswell Park Comprehensive Cancer Cente... Read more
In a Q&A with ILCN, Dr. William K. Evans weighs in on vaping and flavored tobacco regulations as well as cessation and prevention efforts. Read more